These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 25557963

  • 41. Long term outcome in adult males with classic congenital adrenal hyperplasia.
    Cabrera MS, Vogiatzi MG, New MI.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3070-8. PubMed ID: 11443169
    [Abstract] [Full Text] [Related]

  • 42. Growth in congenital adrenal hyperplasia.
    Nguyen AT, Brown JJ, Warne GL.
    Indian J Pediatr; 2006 Jan; 73(1):89-93. PubMed ID: 16444069
    [Abstract] [Full Text] [Related]

  • 43. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [Abstract] [Full Text] [Related]

  • 44. Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia.
    Verma S, Green-Golan L, VanRyzin C, Drinkard B, Mehta SP, Weise M, Eisenhofer G, Merke DP.
    Horm Metab Res; 2010 Jul; 42(8):607-12. PubMed ID: 20446239
    [Abstract] [Full Text] [Related]

  • 45. Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.
    Sarafoglou K, Forlenza GP, Yaw Addo O, Kyllo J, Lteif A, Hindmarsh PC, Petryk A, Gonzalez-Bolanos MT, Miller BS, Thomas W.
    Clin Endocrinol (Oxf); 2017 May; 86(5):708-716. PubMed ID: 28199739
    [Abstract] [Full Text] [Related]

  • 46. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Dörr HG.
    Horm Res; 2007 May; 68 Suppl 5():93-9. PubMed ID: 18174719
    [Abstract] [Full Text] [Related]

  • 47. Serum osteocalcin and insulin-like growth factor I levels in children with congenital adrenal hyperplasia.
    Hargitai G, Hosszú E, Halász Z, Sólyom J.
    Horm Res; 1999 May; 52(3):131-9. PubMed ID: 10725777
    [Abstract] [Full Text] [Related]

  • 48. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.
    Jääskeläinen J, Voutilainen R.
    Pediatr Res; 1997 Jan; 41(1):30-3. PubMed ID: 8979286
    [Abstract] [Full Text] [Related]

  • 49. Height, bone mineral density and bone markers in congenital adrenal hyperplasia.
    Paganini C, Radetti G, Livieri C, Braga V, Migliavacca D, Adami S.
    Horm Res; 2000 Jan; 54(4):164-8. PubMed ID: 11416232
    [Abstract] [Full Text] [Related]

  • 50. Compromised Adult Height in Females with Non-Classical Congenital Adrenal Hyperplasia Diagnosed in Childhood.
    Bello R, Lazar L, Phillip M, de Vries L.
    Horm Res Paediatr; 2023 Jan; 96(5):465-472. PubMed ID: 36806217
    [Abstract] [Full Text] [Related]

  • 51. Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
    Premawardhana LD, Hughes IA, Read GF, Scanlon MF.
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):327-32. PubMed ID: 9156043
    [Abstract] [Full Text] [Related]

  • 52. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.
    Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP.
    J Clin Endocrinol Metab; 2002 May; 87(5):2114-20. PubMed ID: 11994350
    [Abstract] [Full Text] [Related]

  • 53. Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency.
    Reisch N, Rottenkolber M, Greifenstein A, Krone N, Schmidt H, Reincke M, Schwarz HP, Beuschlein F.
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1820-6. PubMed ID: 23969190
    [Abstract] [Full Text] [Related]

  • 54. Long-term consequences of childhood-onset congenital adrenal hyperplasia.
    White PC, Speiser PW.
    Best Pract Res Clin Endocrinol Metab; 2002 Jun; 16(2):273-88. PubMed ID: 12064893
    [Abstract] [Full Text] [Related]

  • 55. [Puberty and growth development in patients with a 21-hydroxylase defect].
    Börger D, Willig RP.
    Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
    [Abstract] [Full Text] [Related]

  • 56. Growth Pattern and Clinical Profile of Indian Children with Classical 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia on Treatment.
    Meena H, Jana M, Singh V, Kabra M, Jain V.
    Indian J Pediatr; 2019 Jun; 86(6):496-502. PubMed ID: 30697677
    [Abstract] [Full Text] [Related]

  • 57. Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.
    Gidlöf S, Hogling DE, Lönnberg H, Ritzén M, Lajic S, Nordenström A.
    Horm Res Paediatr; 2024 Jun; 97(5):445-455. PubMed ID: 38016434
    [Abstract] [Full Text] [Related]

  • 58. Adult height of patients with classical congenital adrenal hyperplasia.
    Tung YC, Lee JS, Tsai WY, Hsiao PH.
    J Formos Med Assoc; 2005 Feb; 104(2):133-6. PubMed ID: 15765171
    [Abstract] [Full Text] [Related]

  • 59. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
    Yu AC, Grant DB.
    Acta Paediatr; 1995 Aug; 84(8):899-903. PubMed ID: 7488814
    [Abstract] [Full Text] [Related]

  • 60. Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience.
    Brunelli VL, Russo G, Bertelloni S, Gargantini L, Balducci R, Chiesa L, Livieri C, De Sanctis C, Einaudi S, Virdis R, Saggese G, Chiumello G.
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():277-83. PubMed ID: 12729404
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.